Advertisement

Loading...

TerrAscend Corp.

TER.CNCNQ
Healthcare
Drug Manufacturers - Specialty & Generic
$2.38
$-0.01(-0.42%)
Canadian Market opens in 16h 14m

TerrAscend Corp. Fundamental Analysis

TerrAscend Corp. (TER.CN) shows weak financial fundamentals with a PE ratio of -2.29, profit margin of -32.13%, and ROE of -72.77%. The company generates $0.3B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.11

Areas of Concern

ROE-72.77%
We analyze TER.CN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -112.4/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-112.4/100

We analyze TER.CN's fundamental strength across five key dimensions:

Efficiency Score

Weak

TER.CN struggles to generate sufficient returns from assets.

ROA > 10%
-15.21%

Valuation Score

Excellent

TER.CN trades at attractive valuation levels.

PE < 25
-2.29
PEG Ratio < 2
-0.11

Growth Score

Weak

TER.CN faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

TER.CN shows balanced financial health with some risks.

Debt/Equity < 1
2.64
Current Ratio > 1
1.38

Profitability Score

Weak

TER.CN struggles to sustain strong margins.

ROE > 15%
-7276.58%
Net Margin ≥ 15%
-32.13%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is TER.CN Expensive or Cheap?

P/E Ratio

TER.CN trades at -2.29 times earnings. This suggests potential undervaluation.

-2.29

PEG Ratio

When adjusting for growth, TER.CN's PEG of -0.11 indicates potential undervaluation.

-0.11

Price to Book

The market values TerrAscend Corp. at 2.03 times its book value. This may indicate undervaluation.

2.03

EV/EBITDA

Enterprise value stands at -0.41 times EBITDA. This is generally considered low.

-0.41

How Well Does TER.CN Make Money?

Net Profit Margin

For every $100 in sales, TerrAscend Corp. keeps $-32.13 as profit after all expenses.

-32.13%

Operating Margin

Core operations generate 15.36 in profit for every $100 in revenue, before interest and taxes.

15.36%

ROE

Management delivers $-72.77 in profit for every $100 of shareholder equity.

-72.77%

ROA

TerrAscend Corp. generates $-15.21 in profit for every $100 in assets, demonstrating efficient asset deployment.

-15.21%

Following the Money - Real Cash Generation

Operating Cash Flow

TerrAscend Corp. generates limited operating cash flow of $23.74M, signaling weaker underlying cash strength.

$23.74M

Free Cash Flow

TerrAscend Corp. produces free cash flow of $13.47M, offering steady but limited capital for shareholder returns and expansion.

$13.47M

FCF Per Share

Each share generates $0.04 in free cash annually.

$0.04

FCF Yield

TER.CN converts 6.30% of its market value into free cash.

6.30%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-2.29

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.11

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.03

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.73

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

2.64

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.38

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.73

vs 25 benchmark

ROA

Return on assets percentage

-0.15

vs 25 benchmark

ROCE

Return on capital employed

0.08

vs 25 benchmark

How TER.CN Stacks Against Its Sector Peers

MetricTER.CN ValueSector AveragePerformance
P/E Ratio-2.2927.91 Better (Cheaper)
ROE-72.77%687.00% Weak
Net Margin-32.13%-45285.00% (disorted) Weak
Debt/Equity2.640.33 Weak (High Leverage)
Current Ratio1.382795.76 Neutral
ROA-15.21%-13557.00% (disorted) Weak

TER.CN outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews TerrAscend Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ